Zealand Pharma chief executive officer Adam Steenberg intends to take on hits like Novo’s Ozempic and Eli Lilly’s Zepbound in the race for the excessive weight market.
发布者:BY KATRINE ALMAND GOTHLER,转转请注明出处:https://robotalks.cn/the-doctor-turned-ceo-aiming-to-beat-obesity-and-ozempic/